Results 1 to 10 of about 54,568 (249)

Antinuclear antibodies in COVID 19 [PDF]

Clinical and Translational Science, 2021
We appreciated very much the interesting study by Chang et al. on the presence of antinuclear antibodies (ANAs) in patients with moderate/critical coronavirus disease 2019 (COVID 19). Both we and Chang and collaborators described the presence and significance of ANAs in patients with COVID‐19.
Paolo Muratori, Marco Lenzi, Luigi Muratori, Alessandro Granito   +3 more
doaj   +4 more sources

Evaluating plasma antinuclear autoantibody profile as a prognostic biomarker in lymphoma [PDF]

BMC Cancer
Background Research on the antinuclear antibodies (ANA) profile across different pathological subtypes of lymphoma was limited. Our study aimed to assess ANA profile and investigate its potential prognostic value in lymphoma.
Cuiling Zheng, Ruyun Gao, Yanrong Wang, Xiaohong Han   +3 more
doaj   +2 more sources

Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis

Biomedicines, 2022
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by the presence of antimitochondrial and antinuclear antibodies in patients’ serum.
Alicja Bauer, Andrzej Habior, Damian Gawel   +2 more
doaj   +1 more source

Antimitochindrial and antinuclear antibodies in primary biliary cholangitis [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy, 2019
In this work we reviewed the key antimitochondrial and antinuclear antibodies in primary biliary cholangitis – an autoimmune cholestatic disorder with destruction of intralobular biliary ductules.
Dana Saipiyeva, Manarbek Askarov, Turlybek Tuganbekov, Kulsara Rustemova, Vladimir Grigorevsky, Gulmira Dossatayeva, Nina Tostanovskaya   +6 more
doaj   +1 more source

A study of clinical manifestations and their association with antinuclear antibodies in various autoimmune connective tissue disorders

Indian Journal of Dermatology, 2023
Background: Autoimmune connective tissue diseases (AICTD) present with a myriad of clinical manifestations, including cutaneous. These disorders occur because of immune dysregulation that produces autoantibodies targeting connective tissue and internal ...
Rupa D Kondeti, K Venkatesh, D. V S. B Rama Murthy, Swapna Kameti, K Sri Devi, K V Chandrika   +5 more
doaj   +1 more source

Can Antinuclear Antibodies (ANA) be Monoclonal?

Case Reports in Nephrology, 2021
Background. Nuclear staining by immunofluorescence in a kidney biopsy is often seen in patients with positive antinuclear antibodies (ANA) in the serum. These ANA are usually polyclonal, but herein we report 9 cases with an unusual finding of monoclonal ...
Laura Biederman, Anjali A. Satoskar, Mohankumar Doraiswamy, Samir Parikh, Brad Rovin, Brian Mussio, Galina Mikhalina, Sergey V. Brodsky   +7 more
doaj   +1 more source

Antimelanocyte antibodies: A possible role in patients with vitiligo

Indian Journal of Dermatology, 2020
Background: Vitiligo is an acquired depigmenting skin disorder with multifactorial pathogenesis including genetic, autoimmune, and neuronal factors. Both humoral- and cell-mediated immunities are supposed to have a role in the pathogenesis of vitiligo ...
Maha A El-Gayyar, Manal E Helmy, Eman R Amer, Moustafa A Elsaied, Mohammad A Gaballah   +4 more
doaj   +1 more source

Antinuclear Antibodies in Children [PDF]

The Journal of Rheumatology, 2014
In this issue of The Journal , Sperotto, et al report on a longitudinal study of antinuclear antibodies (ANA) and chronic noninflammatory musculoskeletal pain (CNI-MSP) in schoolchildren1. Of 261 subjects, 32 children (12.3%) were included based on a positive ANA and 77 (29.5%) based on the presence of CNI-MSP.
Michael Mahler, Marvin J. Fritzler
openaire   +3 more sources

Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children

The Turkish Journal of Pediatrics, 1999
The frequency of antinuclear antibodies (ANA) and rheumatoid factor (RF) was investigated in 118 apparently healthy children (56 male, 62 female). The mean age was 9.8 ± 2.3 years.
Özgür Kasapçopur, Fatma Özbakır, Nil Arısoy, Hüseyin İngöl, Hasan Yazıcı, Huri Özdoğan   +5 more
doaj   +1 more source

Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?

Turkish Journal of Hematology, 2022
Objective: Eltrombopag remains a prominent option in the treatment of steroid-dependent or steroid-refractory immune thrombocytopenia (ITP) patients. Unfortunately, not all patients respond to eltrombopag.
Mehmet Baysal, Volkan Baş, Elif Ümit, Hakkı Onur Kırkızlar, Ahmet Muzaffer Demir   +4 more
doaj   +1 more source